Manufacturer record
Bennet Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
13 batches manufactured by Bennet Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2025 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
13 records linked to Bennet Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40 Mg | BPLT-25104Mfg 2025-05 · Exp 2027-04 | The sample does not conform to I.P. w.r.to the tests for Dissolution.Dissolution | SDTL, AssamState lab | Apr 2026 |
| Telmisartan Tablets IP 40 mg | BPLT-25027Mfg 2025-01 · Exp 2026-12 | The sample does not conform to I.P.w.r.t. the test for DissolutionDissolution | SDTL, AssamState lab | Feb 2026 |
| Telmisartan Tablets IP 40 mg | BPLT-24302Mfg 2024-10 · Exp 2026-09 | The sample does not conform to I.P.w.r.t. the test for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Telmisartan Tablets IP 40 mg | BPLT-25010Mfg 2025-01 · Exp 2026-12 | The sample does not conform to I.P.w.r.t. the test for Dissolution and AssayAssay | SDTL, AssamState lab | Feb 2026 |
| Telmisartan Tablets IP 40 mg | BPLT-25041Mfg 2025-02 · Exp 2027-01 | The sample does not conform to I.P. w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Telmisartan IP 40 mg | BPLT-24335Mfg 2024-10 · Exp 2026-09 | The sample does not conform to I.P.w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Paracetamol Tablets IP 650mg | BPLT-25032Mfg 2025-02 · Exp 2027-01 | The sample does not conforms to the I.P. with respect to Description as black spots are observed on surface of tablets.Description | DTL BikanerState lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | BPLT-25010Mfg 2025-01 · Exp 2026-12 | sample fails the 'Descriptive Part' as per IPOther | DTL ThiruvananthapuramState lab | Jan 2026 |
| Telmisartan Tablets IP 40 mg | BPLT-24205Mfg 2024-08 · Exp 2026-07 | Dissolution, Uniformity of content (Telmisartan)Dissolution | SDTL, GuwahatiState lab | Dec 2025 |
| Telmisartan Tablets IP | 24305Mfg 2024-10 · Exp 2026-09 | The sample is not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab | Dec 2025 |
| Telmisartan Tablets IP 40 mg | BPLT-24302Mfg 2024-10 · Exp 2026-09 | The sample does not conform to IP with respect to the reason stated under Description.Description | CDTL,IndoreCDSCO lab | Nov 2025 |
| Telmisartan Tablets IP 40 mg | BPLT-24305Mfg 2024-10 · Exp 2026-09 | sample is not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Sep 2025 |
| Telmisartan Tablets I.P. 40 mg.. | BPLT-25010Mfg 2025-01 · Exp 2026-12 | sample is declared to be Not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.